Some argue that the CRISPR/Cas9 technology is still in its early stages and its long-term effects on the human genome are not fully understood, thus it may lead to unintended consequences or unpredictable side effects. Additionally, there are concerns about the accessibility and affordability of this technology, as it may only be available to a privileged few, exacerbating social inequalities in healthcare. Lastly, there is a moral and ethical debate about whether we should be intervening in the human genetic code, as it raises questions about the potential for genetic enhancement and designer babies.

Question

(In 1-3 complete sentences, write the counterclaims that you have against the opposing viewpoint.)

Answer 1

Counterclaims against the opposing viewpoint could include the argument that while CRISPR/Cas9 technology is still in its early stages, significant progress has been made in understanding its mechanisms and potential risks, making it increasingly predictable and controllable. Additionally, the argument could be made that concerns about accessibility and affordability can be addressed through scientific advancements and policy regulations, ensuring wider availability and reducing social inequalities. Finally, it could be argued that ethical debates should not overshadow the potential benefits of this technology in addressing genetic diseases and improving human health.

Answer 2